Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,266 | 1,380 | 375 | 0 | 0 |
| Cost of Goods | 2,143 | 1,260 | 20 | N/A | N/A |
| Gross Profit | 123 | 120 | 355 | N/A | N/A |
| Operating Expenses | 67,511 | 172,162 | 160,020 | 106,935 | 82,297 |
| Operating Income | -67,245 | -171,782 | -159,645 | -106,935 | -82,297 |
| Interest Expense | 15,129 | 13,314 | 8,213 | 40 | 27 |
| Other Income | 22,775 | 6,043 | 2,101 | 44 | 155 |
| Pre-tax Income | -59,599 | -179,053 | -165,757 | -106,931 | -82,169 |
| Net Income Continuous | -59,599 | -179,053 | -165,757 | -106,931 | -82,169 |
| Net Income | $-59,599 | $-179,053 | $-165,757 | $-106,931 | $-82,169 |
| EPS Basic Total Ops | -23.51 | -98.33 | -94.72 | -64.80 | -60.64 |
| EPS Basic Continuous Ops | -23.51 | -98.33 | -94.67 | -64.87 | -60.63 |
| EPS Diluted Total Ops | -23.51 | -98.33 | -94.72 | -64.80 | -60.64 |
| EPS Diluted Continuous Ops | -23.51 | -98.33 | -94.67 | -64.87 | -60.63 |
| EPS Diluted Before Non-Recurring Items | -23.51 | -98.40 | -94.72 | -64.80 | -60.64 |
| EBITDA(a) | $-66,936 | $-171,464 | $-159,318 | $-106,638 | $-82,109 |